Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-63,818
Closed -$6.71M 143
2021
Q1
$6.71M Sell
63,818
-21,834
-25% -$2.21M 0.42% 71
2020
Q4
$8.72M Buy
+85,652
New +$8.05M 0.53% 63
2020
Q3
Sell
-54,402
Closed -$4.23M 35
2020
Q2
$3.53M Sell
54,402
-58,370
-52% -$3.85M 0.22% 77
2020
Q1
$7.34M Sell
112,772
-15,545
-12% -$1.22M 0.54% 58
2019
Q4
$10.1M Buy
+128,317
New +$9.99M 0.47% 52

Other funds holding XYL

CQS (US)'s XYL Position: Q2 2021 in Review

CQS (US) sold out of Xylem (XYL) in Q2 2021, closing a stake of 63,818 shares — an estimated $6.71M sold.

CQS (US) first reported a position in XYL in Q4 2019 and held it in 5 quarters. The position peaked at $10.1M in Q4 2019. 771 funds tracked by Wall St. Rank hold XYL as of Q2 2021.

  • CQS (US) reported no remaining Xylem position as of Q2 2021 after selling out during the quarter.
  • CQS (US) sold 63,818 Xylem shares in Q2 2021, an estimated $6.71M.
  • CQS (US) first reported a position in Xylem in Q4 2019 and held it in 5 quarters.
  • CQS (US)'s Xylem position peaked at $10.1M in Q4 2019.
  • 771 funds tracked by Wall St. Rank held Xylem as of Q2 2021.

Based on CQS (US)'s 13F filing for Q2 2021, filed 10 Aug 2021.